Mobilization of Stem Cells With AMD3100 (Plerixafor) in Combination With G-CSF in Multiple Myeloma Patients

NCT05087212 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Autologous Haematopoietic Stem Cell Transplant

Interventions

DRUG: plerixafor + G-CSF

Sponsor

Sanofi